Trade Fresenius SE & Co
Fresenius SE & Co. KGaA is a healthcare company based in Bad Homburg for Hohe, Germany. It provides dialysis products and services, in hospitals, and inpatient and outpatient medical care. It is involved in the management of hospitals, engineering and services for medical and other health-care facilities. Fresenius Medical Care, a publicly traded company that owns 30.8% Fresinius, focuses on patients with chronic renal failure. With its North American headquarters in Waltham, Massachusetts, it has a 38% market share of the Dialysis market in the United States. Fresenius Helios is the largest hospital operator and provider of inpatients and outpatient clinics in Germany. Helios Clinicin has more than 110 hospitals and more than 30,000 beds, treating more than 4 million patients annually. Fresenius Cappie is a supplier of essential medicines, clinical nutrition products, and medical devices. It produces generic versions of intravenous oncology products such as Paclitaxel, Irionottican, Oxaliplatin, Jamesitapine, Citarapine, Carupapine, Tobutipine, Dokitaxel, and ibrupine. the company was founded by Edward Fresinius in 1912.In 1946, Fresinius died. Kroner, his daughter, who was still in the Faculty of Pharmacy at the time, inherited the company. Another Kroner saved the company from significant debts by laying off the majority of employees and restructuring the business. Kroner died in 1988. Kroner's will left all of its assets to the Chroner Fresinius Foundation, which funds medical research. In 1966, the company began selling dialysis machines. In a year 1982, the company became a joint stock company. In 1983, the company began to produce polysulfon fiber membranes. In 1986, the company became a public company, and the listing of shares in Frankfurt shares Exchange.In 1996, the company merged its dialysis business into national medical care to form Fresenius Medical Care.In 1999, the company acquired the international nutrition business of Pharmacia & Upjohn and merged it with Fresinius Pharma to form Fresinius Kabi.In 2001 The company acquired Wittgenenser Klinken, a major operator of private hospitals in Germany.In 2005, which was acquired Helios.In March 2005, acquired Fresenius Cappie AG Labesfal (Laboratório de Eidaspecialdes Farmacêuticas Almiro S.A.). In September 2006, Helios Kleinen acquired a majority stake in Hemen Klein. HUMAINE MANAGES SIX ACUTE CARE HOSPITALS AND THE FIRST IN THE FIELDS OF NEUROLOGY, ONCOLOGy AND TRAUMA.